Dataset Information

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review.

ABSTRACT:

Objective

To determine how the COVID-19 pandemic impacts patients with chronic disease medication adherence.

Methods

Four electronic databases, PubMed, MEDLINE, Web of Science, and CINAHL Plus Full Text, were searched for literature between 2019 and 2021. Abstracts and later full texts were independently screened by the authors of this review using inclusion and exclusion criteria to determine relevance to our study. Joanna Briggs Institute (JBI) critical appraisal tools were used to assess the quality of included texts. Relevant information and data from the included texts were extracted into tables for data synthesis and analysis.

Results

Ten studies met the study criteria, the most popular study design was cross-sectional design (n = 9, 90.0%), others were case series (n = 1, 10.0%). Barriers to medication adherence and facilitators of medication adherence were the major two themes that participants reported regarding the impact of COVID-19 on medication adherence. Moreover, these two main themes have been organized in sub-themes that are dealt with in-depth.

Discussion

Our results could heighten healthcare providers, stakeholders, and policy leaders' awareness of providing appropriate support for chronic disease patients, especially regarding medication adherence. Future research incorporating programs that support patients' needs is recommended.

SUBMITTER: Ruksakulpiwat S

PROVIDER: S-EPMC9382573 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review.

Ruksakulpiwat Suebsarn S Zhou Wendie W Niyomyart Atsadaporn A Wang Tongyao T Kudlowitz Aaron A

Chronic illness 20220816 3

<h4>Objective</h4>To determine how the COVID-19 pandemic impacts patients with chronic disease medication adherence.<h4>Methods</h4>Four electronic databases, PubMed, MEDLINE, Web of Science, and CINAHL Plus Full Text, were searched for literature between 2019 and 2021. Abstracts and later full texts were independently screened by the authors of this review using inclusion and exclusion criteria to determine relevance to our study. Joanna Briggs Institute (JBI) critical appraisal tools were used ...[more]

PMID: 35971949

Similar Datasets

Project description:OBJECTIVE:To determine the economic impact of medication non-adherence across multiple disease groups. DESIGN:Systematic review. EVIDENCE REVIEW:A comprehensive literature search was conducted in PubMed and Scopus in September 2017. Studies quantifying the cost of medication non-adherence in relation to economic impact were included. Relevant information was extracted and quality assessed using the Drummond checklist. RESULTS:Seventy-nine individual studies assessing the cost of medication non-adherence across 14 disease groups were included. Wide-scoping cost variations were reported, with lower levels of adherence generally associated with higher total costs. The annual adjusted disease-specific economic cost of non-adherence per person ranged from $949 to $44 190 (in 2015 US$). Costs attributed to 'all causes' non-adherence ranged from $5271 to $52 341. Medication possession ratio was the metric most used to calculate patient adherence, with varying cut-off points defining non-adherence. The main indicators used to measure the cost of non-adherence were total cost or total healthcare cost (83% of studies), pharmacy costs (70%), inpatient costs (46%), outpatient costs (50%), emergency department visit costs (27%), medical costs (29%) and hospitalisation costs (18%). Drummond quality assessment yielded 10 studies of high quality with all studies performing partial economic evaluations to varying extents. CONCLUSION:Medication non-adherence places a significant cost burden on healthcare systems. Current research assessing the economic impact of medication non-adherence is limited and of varying quality, failing to provide adaptable data to influence health policy. The correlation between increased non-adherence and higher disease prevalence should be used to inform policymakers to help circumvent avoidable costs to the healthcare system. Differences in methods make the comparison among studies challenging and an accurate estimation of true magnitude of the cost impossible. Standardisation of the metric measures used to estimate medication non-adherence and development of a streamlined approach to quantify costs is required. PROSPERO REGISTRATION NUMBER:CRD42015027338.

Dataset Information

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review.

Objective

Methods

Results

Discussion

Publications

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets